The Crucial Impact of Early Intervention in Preventing T1D Stage Progression

Opinion
Video

Addressing the significance of acting early in T1D care, a group of diabetes experts delve into the impact of delaying intervention during stage 2 of the condition.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Prioritizing Blood-Based CRC Tests May Lead to Higher Costs and Worse Outcomes, Study Finds

Prioritizing Blood-Based CRC Tests May Lead to Higher Costs and Worse Outcomes, Study Finds

Sydney Jennings
January 17th 2025
Article

Annual colorectal cancer screening with FIT was the most cost-effective strategy among patients with low adherence, researchers reported.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

CRC Screening Expansion Strains Community Health Centers: Daily Dose / image credit: ©New Africa/AdobeStock

CRC Screening Expansion Strains Community Health Centers: Daily Dose

Sydney Jennings
January 14th 2025
Article

Your daily dose of the clinical news you may have missed.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Mailed FIT Outreach Increases CRC Screening Rates: Daily Dose / image credit: ©New Africa/AdobeStock

Mailed FIT Outreach Increases CRC Screening Rates: Daily Dose

Sydney Jennings
January 3rd 2025
Article

Your daily dose of the clinical news you may have missed.

FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes / Image credit: ©Argus/AdobeStock

FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes

Sydney Jennings
December 23rd 2024
Article

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

© 2025 MJH Life Sciences

All rights reserved.